The Humira Decision and Reverse Payments After Actavis

On March 4, Washington, D.C. antitrust/competition partner Julia York spoke during a webinar hosted by the American Bar Association Section of Intellectual Property Law (ABA-IPL) Antitrust/Interface Committee, and co-sponsored by the ABA-IPL and ABA Antitrust Law Section, titled “The Humira Decision and Reverse Payments After Actavis.” The discussion included analysis of In re Humira Antitrust Litigation, as well as a review of the issues raised on appeal and the development of reverse payment law.